Detalhe da pesquisa
1.
Cancer drugs with high repositioning potential for Alzheimer's disease.
Expert Opin Emerg Drugs
; 28(4): 311-332, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100555
2.
Novel insight into the role of clusterin on intraocular pressure regulation by modifying actin polymerization and extracellular matrix remodeling in the trabecular meshwork.
J Cell Physiol
; 237(7): 3012-3029, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567755
3.
Development of cell-based high throughput luminescence assay for drug discovery in inhibiting OCT4/DNA-PKcs and OCT4-MK2 interactions.
Biotechnol Bioeng
; 118(5): 1987-2000, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565603
4.
Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies.
Anticancer Drugs
; 32(1): 34-43, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079733
5.
Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.
Int J Mol Sci
; 22(12)2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34207035
6.
Deep neuromuscular blockade during spinal surgery reduces intra-operative blood loss: A randomised clinical trial.
Eur J Anaesthesiol
; 37(3): 187-195, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860601
7.
Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia.
Anticancer Drugs
; 30(2): 117-127, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30272587
8.
Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines.
Pediatr Blood Cancer
; 65(12): e27447, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30251395
9.
Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.
Pediatr Blood Cancer
; 65(7): e27023, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29603591
10.
P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Int J Cancer
; 141(2): 405-413, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28340497
11.
Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.
Pediatr Blood Cancer
; 64(4)2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650817
12.
Pharmacodynamic and genomic markers associated with response to the XPO1/CRM1 inhibitor selinexor (KPT-330): A report from the pediatric preclinical testing program.
Pediatr Blood Cancer
; 63(2): 276-86, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26398108
13.
Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 63(10): 1744-52, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238606
14.
Initial Testing of NSC 750854, a Novel Purine Analog, Against Pediatric Tumor Models by the Pediatric Preclinical Testing Program.
Pediatr Blood Cancer
; 63(3): 443-50, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26797892
15.
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Pediatr Blood Cancer
; 63(8): 1349-56, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092812
16.
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.
Exp Cell Res
; 334(1): 78-89, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25845499
17.
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing program.
Pediatr Blood Cancer
; 62(11): 1897-905, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26154614
18.
Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program.
Pediatr Blood Cancer
; 62(6): 1106-9, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25407467
19.
Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.
Pediatr Blood Cancer
; 62(1): 91-8, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25263539
20.
Sectoral variations in the distribution of axonal cytoskeleton proteins in the human optic nerve head.
Exp Eye Res
; 128: 141-50, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25304220